World Allergy Organization Journal· 2020Q1· Review
World Allergy Organization Anaphylaxis Guidance 2020
- 1,109citations
- Q1SCImago
- 2020year
Short summary
The World Allergy Organization (WAO) has updated its 2011 anaphylaxis guidelines, reaffirming intramuscular epinephrine as the first-line treatment while noting its suboptimal use.
AI-generated from the title and abstract; the full text is not read.
Key points
- Intramuscular epinephrine is confirmed as the first-line treatment for anaphylaxis.
- Current use of epinephrine for anaphylaxis remains suboptimal.
- Limited availability and affordability of epinephrine auto-injectors are significant global issues.
- Patients require specialist referral for cause assessment, prevention education, and self-management training.
AI-generated from the title and abstract; the full text is not read.
Abstract
Anaphylaxis is the most severe clinical presentation of acute systemic allergic reactions. The occurrence of anaphylaxis has increased in recent years, and subsequently, there is a need to continue disseminating knowledge on the diagnosis and management, so every healthcare professional is prepared to deal with such emergencies. The rationale of this updated position document is the need to keep guidance aligned with the current state of the art of knowledge in anaphylaxis management. The World Allergy Organization (WAO) anaphylaxis guidelines were published in 2011, and the current guidance adopts their major indications, incorporating some novel changes. Intramuscular epinephrine (adrenaline) continues to be the first-line treatment for anaphylaxis. Nevertheless, its use remains suboptimal. After an anaphylaxis occurrence, patients should be referred to a specialist to assess the potential cause and to be educated on prevention of recurrences and self-management. The limited availability of epinephrine auto-injectors remains a major problem in many countries, as well as their affordability for some patients.
The authors' abstract, as published at the source. World Allergy Organization Journal, 2020 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Immunology and Allergy
Immunology and AllergyMedicine